ArticlePloS one2025
Reconstruction of a genome-scale metabolic model for Streptococcus zooepidemicus: Comparison with Corynebacterium glutamicum to study hyaluronic acid production.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Comparison of Streptococcus zooepidemicus (S. zooepidemicus) as a natural strain for hyaluronic acid (HA) production with Corynebacterium glutamicum (C. glutamicum) as a recombinant host is a valuable tool to identify key metabolic targets for enhanced HA production. For this purpose, a comparative analysis based on the genome-scale metabolic networks of native and recombinant HA producers was conducted. In this study, the first genome-scale metabolic model (GEM) of S. zooepidemicus, was reconstructed and named iZN522. This systematically curated model was validated using various biochemical data, consisting of growth rate prediction, amino acids auxotrophy, and different carbon sources consumption. Following the validation, key genes for HA overproduction in both bacteria were identified through iterative single-gene deletion analysis. Comparing optimal flux distributions predicted by models of S. zooepidemicus strain with recombinant C. glutamicum revealed that removing the oxidative pentose-phosphate pathway in C. glutamicum effectively increases the hyaluronan synthase flux. Additionally, improvement strategies in C. glutamicum primarily rely on up- and down-regulation, while in S. zooepidemicus, gene deletions can optimize the HA production rate. By comparing the two metabolic models, it can be inferred that eliminating of glucose-6-phosphate dehydrogenase enzymatic reaction in C. glutamicum results in greater similarity in the central carbon metabolisms of C. glutamicum and S. zooepidemicus, thereby enhancing HA production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.